Scientists have made a breakthrough in the study of Down's syndrome after discovering a method to prevent the chromosomal disorder in the womb itself.
In the study on mice, the scientists observed that when foetal mouse pups that had a syndrome similar to Down's were treated with nerve-protecting chemicals, some of the developmental delays that are part of the condition were removed.
Genetic Testing of Diseases
Genetic testing helps to confirm a genetic condition in an individual and involves q complex laboratory techniques
Advertisement
Kids with Down's have an extra copy of chromosome 21, while mice engineered to have a similar condition are given an extra copy of a segment of chromosome 16.
In both species, the development of certain motor and sensory abilities is delayed. These "trisomic" individuals may also have learning difficulties and symptoms of Alzheimer's later in life.
![Son’s Down Syndrome Ignored, German Doctor Gets Permanent Residency In Australia]( "Son’s Down Syndrome Ignored, German Doctor Gets Permanent Residency In Australia")
Australian authorities have reversed their earlier decision not to give permanent residency to German doctor Berhard Moeller because of his son's health.
The scientists found that inhibition of neurotransmitter GABA in trisomic mice can improve cognition and this could eventually be used in children.
In fact, many researchers have claimed that treating Down's before a child is born would improve cognitive potential too.
Earlier studies both of people with Down's and trisomic mice revealed malfunctions in glial cells - brain cells that regulate the development of neurons by releasing certain proteins. The aberrant cells produce less of these proteins than normal. And adding segments of some of these proteins - known as NAP and SAL - to cultured neurons from people with Down's, which would otherwise degenerate, seems to protect the neurons.
Using the above information, researchers led by Catherine Spong at the National Institutes of Health in Bethesda, Maryland, injected NAP and SAL into mice pregnant with trisomic pups in the middle of their pregnancy.
After birth, the pups reached developmental milestones such as grasping a rod, righting themselves and responding to tactile stimulation at the same time as normal mice.
"We were able to prevent a significant amount of the delay," New Scientist quoted Spong as saying.
When the pups were born, they reached developmental milestones at the same time as normal mice
The brains of the treated mice also showed normal levels of ADNP - one of the regulatory proteins underproduced by Down's-affected glial cells - and of another compound that is a marker for healthy glial cells.
Both findings indicate that some effects of Down's had been removed.
Source: ANI
SPH
Son’s Down Syndrome Ignored, German Doctor Gets Permanent Residency In Australia
Australian authorities have reversed their earlier decision not to give permanent residency to German doctor Berhard Moeller because of his son's health.
Advertisement
The scientists found that inhibition of neurotransmitter GABA in trisomic mice can improve cognition and this could eventually be used in children.
In fact, many researchers have claimed that treating Down's before a child is born would improve cognitive potential too.
Earlier studies both of people with Down's and trisomic mice revealed malfunctions in glial cells - brain cells that regulate the development of neurons by releasing certain proteins. The aberrant cells produce less of these proteins than normal. And adding segments of some of these proteins - known as NAP and SAL - to cultured neurons from people with Down's, which would otherwise degenerate, seems to protect the neurons.
Using the above information, researchers led by Catherine Spong at the National Institutes of Health in Bethesda, Maryland, injected NAP and SAL into mice pregnant with trisomic pups in the middle of their pregnancy.
After birth, the pups reached developmental milestones such as grasping a rod, righting themselves and responding to tactile stimulation at the same time as normal mice.
"We were able to prevent a significant amount of the delay," New Scientist quoted Spong as saying.
When the pups were born, they reached developmental milestones at the same time as normal mice
The brains of the treated mice also showed normal levels of ADNP - one of the regulatory proteins underproduced by Down's-affected glial cells - and of another compound that is a marker for healthy glial cells.
Both findings indicate that some effects of Down's had been removed.
Source: ANI
SPH
New Study Could Help Improve Teaching Techniques for Children With Down Syndrome
A groundbreaking study is on in the US to find out how young children afflicted by the Down Syndrome learn. The study could help refine techniques of teaching such disadvantaged children.
Advertisement
Advertisement
|
Advertisement
Latest Research News
Reducing the production of Snail post-brain injury leads to heightened inflammation and amplified cell mortality.
For individuals with inflammatory bowel disease (IBD), the routine act of eating and nutrient absorption can vary significantly.
Painful realities of racial discrimination and bias are increasingly acknowledged as harmful to the well-being.
Role of flaxseed in the relationship between gut microorganisms and mammary gland microRNAs has been uncovered by a new study.
New mRNA stem cell therapy, akin to COVID-19 vaccine tech, shows potential against chronic and acute liver diseases.